An interventional study of A PEEP trial performed with the PulmoVista® 500 (Dräger, Lübeck, Germany) is a procedure designed to identify the optimal level of positive end-expiratory pressure in Electrical Impedance Tomography, sponsored by ASST Fatebenefratelli Sacco. Recruiting at 1 site in Italy. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-04.
Sponsored by ASST Fatebenefratelli Sacco · Not applicable, Interventional, and Prevention
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Background:
Laparoscopic surgery has gained widespread adoption due to its minimally invasive nature, offering advantages such as reduced postoperative pain, shorter hospitalization, and faster functional recovery compared with traditional open surgery. Nevertheless, postoperative respiratory complications remain a major source of morbidity. Factors such as general anesthesia, the Trendelenburg position, and CO₂ pneumoperitoneum can impair respiratory mechanics, reduce total lung capacity, and promote atelectasis, leading to compromised gas exchange.
Rationale:
Positive end-expiratory pressure (PEEP) is routinely applied to prevent alveolar collapse and improve oxygenation during mechanical ventilation. However, the use of standardized, non-individualized PEEP levels may be suboptimal, as inappropriate settings can cause alveolar overdistension or persistent collapse. Personalized PEEP titration, tailored to patient-specific lung mechanics, has recently emerged as a promising strategy to minimize ventilator-induced lung injury (VILI).
Methods and Tools:
Electrical Impedance Tomography (EIT) is a non-invasive, bedside monitoring technique that enables real-time assessment of regional lung ventilation. By evaluating ventilated and non-ventilated lung areas, EIT can guide PEEP optimization and support individualized ventilatory management. Recent studies suggest that EIT-guided PEEP titration improves respiratory parameters and reduces atelectasis in patients undergoing major surgery.
Objective:
The present study aims to evaluate the efficacy of EIT-guided PEEP personalization in patients undergoing laparoscopic and robotic surgery. Primary endpoints include improvements in regional ventilation, respiratory system compliance, and intraoperative gas exchange, as well as postoperative pulmonary function.
Laparoscopic surgery has become an increasingly widespread surgical approach due to its minimally invasive nature, which allows for reduced postoperative pain, shorter hospital stays, and faster functional recovery compared to traditional open surgery. However, despite these advantages, laparoscopic procedures are not free from postoperative respiratory complications, which remain among the leading causes of postoperative morbidity. The combination of general anesthesia, the Trendelenburg position, and insufflation of CO₂ into the abdominal cavity can alter respiratory mechanics, reduce total lung capacity, and promote the development of atelectatic areas, resulting in impaired gas exchange (1-2).
Positive end-expiratory pressure (PEEP) is a widely used strategy to prevent alveolar collapse and improve oxygenation during mechanical ventilation. Nevertheless, the application of a standardized, non-individualized PEEP level may not be optimal for all patients, and an inappropriate PEEP setting may lead to alveolar overdistension or persistence of collapsed areas (3). Recently, personalized PEEP titration has gained attention as a method to tailor ventilation settings to individual patient characteristics, thereby minimizing the risk of ventilator-induced lung injury (VILI) (4).
Electrical Impedance Tomography (EIT) is a non-invasive, bedside imaging technique that enables real-time assessment of the regional distribution of pulmonary ventilation. EIT allows continuous monitoring of the effects of PEEP on both ventilated and non-ventilated lung regions and can guide the optimization of individualized PEEP levels to improve ventilation distribution and reduce the risk of respiratory complications (5-6). Recent studies have shown that the use of EIT-guided PEEP personalization in patients undergoing major surgery can improve respiratory parameters and reduce atelectasis formation (7-8). Specifically, EIT enables the performance of a PEEP trial, during which the device identifies areas of alveolar overdistension or collapse in response to PEEP changes, thereby guiding personalized ventilatory settings.
However, the application of this technique in the context of laparoscopic surgery remains limited. This study aims to evaluate the effectiveness of EIT-guided PEEP personalization in patients undergoing laparoscopic and robotic procedures, with the goal of improving regional ventilation, respiratory system compliance, and intraoperative gas exchange, as well as postoperative pulmonary function.
ASST Fatebenefratelli Sacco is the lead sponsor of 38 studies on the registry; 12 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
COPD
Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
PEEP value will be decided by clinician
PEEP value will be set after a PEEP trial performed with EIT machine
Device: A PEEP trial performed with the PulmoVista® 500 (Dräger, Lübeck, Germany) is a procedure designed to identify the optimal level of positive end-expiratory pressure
During the trial, stepwise adjustments of PEEP are made while EIT provides real-time, bedside visualization of ventilation distribution across different lung regions. Typically, the protocol involves a recruitment maneuver followed by incremental and/or decremental PEEP steps (for example, in 2-3 cmH₂O intervals). At each step, EIT measures changes in regional impedance, which reflect variations in local lung aeration and ventilation. By analyzing these parameters, clinicians can determine the individualized "best PEEP", defined as the point at which alveolar collapse is minimized without causing significant overdistension. The optimal PEEP is then set for subsequent ventilation management.
Static respiratory system compliance
Respiratory system compliance is equivalent to tidal volume divided by the diiference between plateau and PEEP pressure. Unit of measurement is cmH2O/mL
Time frame: - Baseline (after anesthesia induction) - T1 (After Trendelemburg position and induction of pneumoperitoneum) - T2 (After PEEP trial) - T3 (90 minutes after PEEP trial) - T4 (180 minutes after PEEP trial) - T5 (Before end of anesthesia)
Plan to share: No
Started Jan 2026 (actual). Primary completion is estimated for Oct 2026, 9 months after the start.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
ASST Fatebenefratelli Sacco